Consistent with this concept, we observed significantly higher stemness scores in patients with high MRPL3 expression, suggesting that MRPL3 may indicate a more aggressive tumor phenotype and serve as a prognostic marker for PC. The gene discussed is MRPL3; the disease is pachyonychia congenita.